India  

Panel recommends permission to Serum Institute for phase 2, 3 human clinical trials of Oxford vaccine candidate

IndiaTimes Friday, 31 July 2020 ()
A subject expert committee on Covid-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute of India (SII) for conducting the second and third phases of human clinical trials of the Oxford vaccine candidate.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Moderna vaccine protects monkeys, next: 30,000 humans on trial | Oneindia News

Moderna vaccine protects monkeys, next: 30,000 humans on trial | Oneindia News 02:53

India welcomes first 5 Rafale jets at Ambala air base, all 36 to be delivered by end-2021; Mehbooba Mufti's daughter Iltija Mufti says 'mother won't blink first' on her detention in Kashmir; Rajasthan Governor Kalraj Mishra cancels Independence Day event over Covid-19, the same reason for which he...

You Might Like


💡 newsR Knowledge: Other News Mentions

Oxford University Police Oxford University Police

Coronavirus: Oxford University vaccine found to produce COVID-19 antibodies [Video]

Coronavirus: Oxford University vaccine found to produce COVID-19 antibodies

The experimental COVID-19 vaccine has produced an immune system response in hundreds of volunteers as part of its early clinical trial.View on euronews

Credit: euronews (in English)    Duration: 02:18Published
'Very positive': UK vaccine prompts immune response in [Video]

'Very positive': UK vaccine prompts immune response in

Early results indicate Oxford University's COVID-19 vaccine is safe and triggers immune response.

Credit: Al Jazeera STUDIO    Duration: 04:44Published
Covid-19 vaccine: "New results are very encouraging" [Video]

Covid-19 vaccine: "New results are very encouraging"

The Oxford University vaccine team has published its phase one trial data. The findings suggest the Covid-19 vaccine is safe and induces an immune reaction. Professor Andrew Pollard says that the "new results are very encouraging". Report by Bassaneseg. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 02:01Published
UK coronavirus vaccine shows early promise [Video]

UK coronavirus vaccine shows early promise

Oxford University scientists say experimental vaccine prompts a protective immune response in its first human trial.

Credit: Al Jazeera STUDIO    Duration: 10:06Published

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

Congress MP Karti Chidambaram tests positive for coronavirus [Video]

Congress MP Karti Chidambaram tests positive for coronavirus

Congress MP Karti Chidambaram and son of former finance minister P. Chidambaram tested positive for COVID-19. Junior Chidambaram experiencing mild symptoms and is under home quarantine. Earlier on August 02, Union Home Minister Amit Shah and Karnataka CM BS Yediyurappa also tweeted that he had tested positive for COVID.

Credit: ANI    Duration: 01:00Published
New 90-minute tests for Covid-19 to be rolled out [Video]

New 90-minute tests for Covid-19 to be rolled out

Two tests which can detect coronavirus and flu – and promise results in 90minutes – are to be rolled out in hospitals, care homes and laboratories. Theswab and DNA tests will help deal with the virus in winter, enablingclinicians and NHS Test and Trace to differentiate between Covid-19, whichrequires sufferers to undergo specific self-isolation, and other seasonalillnesses, the Department of Health said.

Credit: PA - Press Association STUDIO    Duration: 01:19Published

Covid-19 tests in India cross 2-crore mark

The total number of tests for detection of COVID-19 has crossed the two-crore mark in India, according to the Indian Council of Medical Research (ICMR) data.
IndiaTimes

Lok Sabha MP Karti Chidambaram tests positive for Covid-19

"I have just tested positive for #Covid. My symptoms are mild and as per medical advice I am under home quarantine. I would urge all those who have recently been..
IndiaTimes

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

Coronavirus vaccine: DCGI gives nod to Serum-Oxford for phase 2, 3 clinical trials in India

DCGI has allowed the Serum Institute of India to conduct phase 2 and 3 human clinical trials in India on the potential COVID19 vaccine.
DNA

COVID-19: DCGI nod to Serum Institute of India for phase 2 and 3 human clinical trials of Oxford vaccine candidate

Government officials told PTI that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after..
IndiaTimes

DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine

A CDSCO expert panel has sought clarifications from Serum Institute of India (SII) over its application to the DCGI seeking permission for conducting phase 2 and..
IndiaTimes

Related videos from verified sources

'Cautiously optimistic US could have Covid vaccine by 2020 end': Anthony Fauci [Video]

'Cautiously optimistic US could have Covid vaccine by 2020 end': Anthony Fauci

Top US epidemiologist Dr Anthony Fauci said that he is cautiously optimistic about Covid-19 vaccine. Fauci said the vaccine for Covid-19 may be available by the end of the year. Appearing before a..

Credit: HT Digital Content     Duration: 03:21Published
Meharry Medical College asks communities of color to participate in COVID-19 vaccine trials [Video]

Meharry Medical College asks communities of color to participate in COVID-19 vaccine trials

President of Meharry Medical College, Dr. James Hildreth says the medical school will be working alongside the makers of a new COVID-19 vaccine by enrolling community members in the trial study. But..

Credit: NewsChannel 5 Nashville     Duration: 01:52Published
Covid update: India on herd immunity; Kolkata extends flight ban till Aug 15 [Video]

Covid update: India on herd immunity; Kolkata extends flight ban till Aug 15

From India stating that herd immunity is not a strategic option yet, to Kolkata extending flight ban, here are the top updates on coronavirus. Health Ministry on Thursday said herd immunity is not a..

Credit: HT Digital Content     Duration: 03:30Published

Related news from verified sources

DCGI nod to Serum Institute of India for phase 2 and 3 human clinical trials of Oxford vaccine candidate

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2...
Zee News Also reported by •IndiaTimesMid-DayHindu

India readies 5 sites for Oxford vaccine trials

Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca Covid-19 vaccine, Department of Biotechnology...
IndiaTimes Also reported by •Mid-DayHindu

Tweets about this

explorediary

nationfirst🇮🇳 @Raghvarma DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine https://t.co/g5sCB95nKC 18 hours ago

iamnarendranath

Narendra nath mishra RT @HealthwireMedia: DCGI Asks Serum Institute To Revise Protocol For Phase 2, 3 Trials Of Oxford COVID-19 Vaccine https://t.co/EkxCiBfKIZ 2 days ago

HealthwireMedia

Healthwire DCGI Asks Serum Institute To Revise Protocol For Phase 2, 3 Trials Of Oxford COVID-19 Vaccine https://t.co/EkxCiBfKIZ 2 days ago

amanshukla

Amandeep Shukla RT @payaljourno: My story @PTI_News DCGI asks Serum Institute to revise protocol for phase 2 3 trials of Oxford COVID-19 vaccine https://t.… 2 days ago

Officialamit___

Amit Rajbhar 💫 RT @indiatvnews: Serum Institute asked to revise protocol to conduct Oxford's coronavirus vaccine Phase 2, 3 human trials #Oxford #OxfordVa… 3 days ago

indiatvnews

India TV Serum Institute asked to revise protocol to conduct Oxford's coronavirus vaccine Phase 2, 3 human trials #Oxford… https://t.co/5R7wOaKTip 3 days ago

medicaldialogs

Medical Dialogues DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine @SerumInstIndia… https://t.co/UIzWzYFqqU 3 days ago

GauravR_Mishra

गौरव आर मिश्रा/Gaurav R Mishra Oxford Coronavirus vaccine: DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 v… https://t.co/BzU4XFjCBT 3 days ago